MOSPD2 is a therapeutic target for the treatment of CNS inflammation.

Yacov, N; Kafri, P; Salem, Y; Propheta-Meiran, O; Feldman, B; Breitbart, E; Mendel, I

Yacov, N; Kafri, P; Salem, Y; Propheta-Meiran, O; Feldman, B; Breitbart, E; Mendel, I.

Affiliation

Yacov N; VBL Therapeutics, Modi'in, Israel.
Kafri P; VBL Therapeutics, Modi'in, Israel.
Salem Y; VBL Therapeutics, Modi'in, Israel.
Propheta-Meiran O; VBL Therapeutics, Modi'in, Israel.
Feldman B; VBL Therapeutics, Modi'in, Israel.
Breitbart E; VBL Therapeutics, Modi'in, Israel.
Mendel I; VBL Therapeutics, Modi'in, Israel.

Clin Exp Immunol ; 201(2): 105-120, 2020 08.

Article in En | MEDLINE | ID: mdl-32353176

Subject(s)

Central Nervous System/immunology; Encephalomyelitis, Autoimmune, Experimental/metabolism; Inflammation/metabolism; Membrane Proteins/metabolism; Monocytes/immunology; Multiple Sclerosis/metabolism; Receptors, Chemokine/metabolism; T-Lymphocytes/immunology; Animals; Cell Movement; Cells, Cultured; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental/genetics; Encephalomyelitis, Autoimmune, Experimental/therapy; Female; Humans; Inflammation/genetics; Inflammation/therapy; Interleukin-4/metabolism; Membrane Proteins/genetics; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiple Sclerosis/genetics; Multiple Sclerosis/therapy; Receptors, Chemokine/genetics; Th1-Th2 Balance

Key words

EAE; MOSPD2; Myeloid; migration

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Monocytes / T-Lymphocytes / Central Nervous System / Receptors, Chemokine / Encephalomyelitis, Autoimmune, Experimental / Inflammation / Membrane Proteins / Multiple Sclerosis Type of study: Prognostic_studies Limits: Animals / Female / Humans Language: En Journal: Clin Exp Immunol Year: 2020 Document type: Article

Fulltext

XML

PubMed Links

Search on Google